Mario Alba is a partner in Robbins Geller Rudman & Dowd LLP’s Melville office. He is a member of the Firm’s Institutional Outreach Team, which provides advice to the Firm’s institutional clients, including numerous public pension systems and Taft-Hartley funds throughout the United States, and consults with them on issues relating to corporate fraud in the U.S. securities markets, as well as corporate governance issues and shareholder litigation. Some of Mario’s institutional clients are currently involved in securities cases involving: Acadia Healthcare Company, Inc.; Reckitt Benckiser Group plc; Livent Corporation; Ryanair Holdings plc; Southwest Airlines Co.; Impax Laboratories Inc.; Super Micro Computer, Inc.; Skechers USA, Inc.; and XPO Logistics, Inc. Mario’s institutional clients are also involved in other types of class actions, namely: In re National Prescription Opiate Litigation, In re Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation, Forth v. Walgreen Co., and In re Humira (Adalimumab) Antitrust Litigation.
